The START study is a multicenter randomized, placebo-controlled Phase 2 study designed to evaluate the efficacy and safety of two doses of an…
ACCLAIM-Lp(a) is a clinical research study for people who have or are at risk for heart disease, stroke, or peripheral artery disease. Lipoprotein(a…
Nmra-335140-301 (Koastal-1) A Phase 3, Randomized, Double-blind, Placebo-controlled Study To Evaluate The Effects Of Oral Nmra-335140 Versus Placebo…
PTSD is a debilitating condition with poorly understood physiology. Through the use of medical imaging, we seek to visualize AMPA receptor density…
Study to Demonstrate the Value of Time-Varying Patterns for Spinal Cord Stimulation in the Treatment of Chronic PainThe goal of this study is to…
Researchers at the Children's Nutrition Research Center at Baylor College of Medicine are looking for parents and their 10-12-year-olds to…
A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to determine the Efficacy and Safety of LASN01 in Patients with…
Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural…
Through this research study, individuals ages 45-69 may qualify for a free cancer screening, not yet available to the public. Have questions?…
VRDN-001-301 A randomized, double-masked, placebo-controlled safety, tolerability, and efficacy study of VRDN-001, a humanized monoclonal antibody…